Key result
Decompensated heart failure was associated with significantly higher liver stiffness compared to healthy controls (2.03 vs 1.17 m/s), which subsequently decreased following optimal medical treatment.
Why the study?
Does virtual touch quantification (VTQ) elastography accurately assess liver congestion and correlate with central venous pressure in patients with heart failure?
Observational (n=48)
No
Does virtual touch quantification (VTQ) elastography accurately assess liver congestion and correlate with central venous pressure in patients with heart failure?
Absolute Event Rate: 2.03% vs 1.17%
p-value: p=0.004
Liver stiffness measured by noninvasive VTQ elastography correlates significantly with central venous pressure and can be used to assess liver congestion and therapeutic response in heart failure patients.
Supports VTQ elastography for assessing liver congestion and treatment response in HF; hypothesis-generating and requires prospective validation.
BACKGROUND: Heart failure (HF) causes organ congestion, which is thought to increase organ stiffness. The virtual touch quantification (VTQ) method can be used to assess liver stiffness in patients with chronic liver diseases. This study aimed to measure liver and kidney stiffness using VTQ and to determine its value for assessing organ congestion in patients with HF. METHODS AND RESULTS: This study included 10 normal subjects and 38 HF patients (age 52.3±16.7 years, left ventricular ejection fraction 27.0±9.4%, plasma B-type natriuretic peptide [BNP] 1,297.3±1,155.1 pg/ml). We investigated the relationships between clinical characteristics and hemodynamics and liver and kidney stiffness, and assessed the effects of medical treatment on these measurements. Liver stiffness was significantly higher in HF patients (1.17±0.13 m/s vs. 2.03±0.91 m/s, P=0.004) compared with normal subjects, but kidney stiffness was similar in both groups. Central venous pressure (CVP) (P=0.021) and BNP (P=0.025) were independent predictive factors for increased liver stiffness in HF patients. Liver stiffness decreased significantly from 2.37±1.09 to 1.27±0.33 m/s (P<0.001) after treatment. Changes in liver stiffness in HF patients significantly correlated with changes in CVP (R=0.636, P=0.014) and cardiac index (R=-0.557, P=0.039) according to univariate analysis, and with changes in CVP in multivariate analysis. CONCLUSIONS: Liver stiffness measured by noninvasive VTQ methods can be used to assess liver congestion and therapeutic effects in patients with HF. (Circ J 2016; 80: 1187-1195).
No takes yet. Share an insight, caveat, or question.
Yoshitani et al. (2016) conducted an observational in Heart failure (n=48). Decompensated heart failure vs. Healthy controls was evaluated on Liver stiffness (shear-wave velocity) (p=0.004). Decompensated heart failure was associated with significantly higher liver stiffness compared to healthy controls (2.03 vs 1.17 m/s), which subsequently decreased following optimal medical treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: